Biote Q2 rev $48.9M, net income $3.9M vs year-ago loss; Adj. EBITDA up 19%

biote Corp.

2025-Q2 EPS reported $0.46 revenue$97,855,000

Revenue $48.9M, gross margin 71.6%; net income $3.9M ($0.10 diluted EPS) vs net loss $10.4M ($0.21 loss) in Q2 2024.
Adjusted EBITDA $15.2M (margin 31.1%), up 19.1% YoY; benefit from Q3 shift of annual marketing event and 503B vertical integration.
CEO announced organizational restructuring in early May to accelerate new provider and clinic growth; new leadership and upgraded sales compensation.
Q2 revenue decreased slightly YoY, but profitability and margins expanded significantly.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.